These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33287246)

  • 1. Antifungal Activity and Molecular Mechanisms of Partial Purified Antifungal Proteins from
    Jeenkeawpieam J; Yodkeeree S; Andrianopoulos A; Roytrakul S; Pongpom M
    J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33287246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and Mechanism of Cotrimoxazole Against Talaromyces marneffei in vitro.
    Chen J; Chen R; Wei W; Qin F; Chen X; He J; Zhang H; Wang G; Shi M; Qin T; Liao Y; Wu Y; Lu B; Tao X; Ye L; Liang H; Jiang J
    Mycopathologia; 2022 Dec; 187(5-6):579-593. PubMed ID: 36318375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin A Is Essential in the Regulation of Asexual Development, Stress Responses and Pathogenesis in
    Zheng YQ; Pan KS; Latgé JP; Andrianopoulos A; Luo H; Yan RF; Wei JY; Huang CY; Cao CW
    Front Microbiol; 2019; 10():3094. PubMed ID: 32038542
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Partitivirus Enhances Virulence of and Causes Aberrant Gene Expression in Talaromyces marneffei.
    Lau SKP; Lo GCS; Chow FWN; Fan RYY; Cai JJ; Yuen KY; Woo PCY
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895639
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifungal activity of marine-derived actinomycetes against Talaromyces marneffei.
    Sangkanu S; Rukachaisirikul V; Suriyachadkun C; Phongpaichit S
    J Appl Microbiol; 2021 May; 130(5):1508-1522. PubMed ID: 33010096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of
    Kai-Su P; Hong L; Dong-Yan Z; Yan-Qing Z; Andrianopoulos A; Latgé JP; Cun-Wei C
    Front Microbiol; 2022; 13():1033211. PubMed ID: 36452929
    [No Abstract]   [Full Text] [Related]  

  • 7. In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei.
    Luo H; Pan KS; Luo XL; Zheng DY; Andrianopoulos A; Wen LM; Zheng YQ; Guo J; Huang CY; Li XY; Hu R; Li YJ; Li TM; Joseph J; Cao CW; Liang G
    Mycopathologia; 2019 Apr; 184(2):295-301. PubMed ID: 30805832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talaromyces marneffei infection in a lung cancer patient: a rare case report.
    Lin F; Qiu Y; Zeng W; Liang Y; Zhang J
    BMC Infect Dis; 2019 Apr; 19(1):336. PubMed ID: 31014277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.
    Chan JF; Lau SK; Yuen KY; Woo PC
    Emerg Microbes Infect; 2016 Mar; 5(3):e19. PubMed ID: 26956447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions.
    Ge Y; Xu Z; Hu Y; Huang M
    J Infect Chemother; 2019 Mar; 25(3):204-207. PubMed ID: 30195473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analysis provides insights into the transmission and pathogenicity of Talaromyces marneffei.
    Li Y; Luo H; Fan J; Lan X; Liu G; Zhang J; Zhong X; Pang Y; Wang J; He Z
    Fungal Genet Biol; 2019 Sep; 130():54-61. PubMed ID: 31075360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.
    Cao C; Xi L; Chaturvedi V
    Mycopathologia; 2019 Dec; 184(6):709-720. PubMed ID: 31811603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the possible regulation of the expression of genes by yapA in Talaromyces marneffei using the qRT- PCR method.
    Dankai W; Pongpom M; Vanittanakom N
    Med Mycol; 2018 Aug; 56(6):735-745. PubMed ID: 29228272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.
    Wang P; Chen Y; Xu H; Ding L; Wu Z; Xu Z; Wang K
    Mycopathologia; 2017 Aug; 182(7-8):751-754. PubMed ID: 28349349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Disseminated
    Hatakeyama S; Yamashita T; Sakai T; Kamei K
    Am J Trop Med Hyg; 2017 Jul; 97(1):38-41. PubMed ID: 28719322
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatoscopy for the rapid diagnosis of Talaromyces marneffei infection: a case report.
    Xian J; Huang X; Li Q; Peng X; Peng X
    BMC Infect Dis; 2019 Aug; 19(1):707. PubMed ID: 31399065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic analysis of the pathogenic mechanism of talaromyces marneffei infection.
    Cen J; Chen J; Qiu Y; Zeng W; Zhang J
    Medicine (Baltimore); 2020 Nov; 99(48):e23409. PubMed ID: 33235120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talaromyces marneffei laccase modifies THP-1 macrophage responses.
    Sapmak A; Kaewmalakul J; Nosanchuk JD; Vanittanakom N; Andrianopoulos A; Pruksaphon K; Youngchim S
    Virulence; 2016 Aug; 7(6):702-17. PubMed ID: 27224737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report.
    Pan M; Qiu Y; Zeng W; Tang S; Wei X; Zhang J
    BMC Infect Dis; 2020 Jun; 20(1):394. PubMed ID: 32493232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.